{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:20:53Z","timestamp":1787862053767,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1053\/apmr.2001.25141","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"1155-1163","source":"Crossref","is-referenced-by-count":69,"title":["Prospective assessment of tizanidine for spasticity due to acquired brain injury"],"prefix":"10.1053","volume":"82","author":[{"given":"Jay M.","family":"Meythaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Guin-Renfroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/apmr.2001.25141_bib1","first-page":"96","article-title":"Drug therapy: spasticity (first of two parts)","volume":"304","author":"Young","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/apmr.2001.25141_bib2","first-page":"28","article-title":"Drug therapy: Spasticity (second of two parts)","volume":"304","author":"Young","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/apmr.2001.25141_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00002060-198806000-00004","article-title":"Management of spasticity","volume":"67","author":"Katz","year":"1988","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","article-title":"Continuously infused intrathecal baclofen for spastic\/dystonic hemiplegia: a preliminary report","volume":"78","author":"Meythaler","year":"1999","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0003-9993(99)90301-5","article-title":"Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience","volume":"80","author":"Meythaler","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mus.880190404","article-title":"Time course of muscle atrophy and recovery following a phenol-induced nerve block","volume":"19","author":"Bodine-Fowler","year":"1996","journal-title":"Muscle Nerve"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib7","first-page":"S44","article-title":"Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group","volume":"44","author":"Nance","year":"1994","journal-title":"Neurology"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib8","first-page":"S34","article-title":"Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group","volume":"44","author":"Smith","year":"1994","journal-title":"Neurology"},{"key":"10.1053\/apmr.2001.25141_bib9","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1001\/jama.1993.03510200081036","article-title":"Continuous intrathecal baclofen infusion for spasticity of cerebral origin","volume":"270","author":"Albright","year":"1993","journal-title":"JAMA"},{"key":"10.1053\/apmr.2001.25141_bib10","first-page":"205","article-title":"The Ashworth scale: a reliable and reproducible method of measuring spasticity","volume":"3","author":"Lee","year":"1989","journal-title":"J Neurol Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib11","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1053\/apmr.2001.25141_bib12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/apmr.2001.25141_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0003-9993(96)90034-9","article-title":"Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury","volume":"77","author":"Meythaler","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study","volume":"78","author":"Coffey","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1053\/apmr.2001.25141_bib15","series-title":"Guide for use of the uniform data set for medical rehabilitation (Adult FIM), version 4.0","author":"Granger","year":"1993"},{"key":"10.1053\/apmr.2001.25141_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0003-9993(93)90153-2","article-title":"Relationship between impairment and physical disability as measured by the functional independence measure","volume":"74","author":"Heinemann","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib17","first-page":"519","article-title":"Quantifying handicap: a new measure of long-term rehabilitation outcomes","volume":"73","author":"Whiteneck","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00003086-198706000-00013","article-title":"A major complication of craniocerebral trauma","volume":"219","author":"Yarkony","year":"1987","journal-title":"Clin Orthop"},{"key":"10.1053\/apmr.2001.25141_bib19","first-page":"825","article-title":"Rehabilitation of the patient with traumatic brain injury","author":"Whyte","year":"1993"},{"key":"10.1053\/apmr.2001.25141_bib20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/jnnp.37.12.1352","article-title":"Segmental reflex pathways in spinal shock and spinal spasticity in man","volume":"37","author":"Ashby","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib21","first-page":"S6","article-title":"Tizanidine: neuropharmacology and mechanism of action","volume":"44","author":"Coward","year":"1994","journal-title":"Neurology"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib22","first-page":"S21","article-title":"Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity","volume":"44","author":"Delwaide","year":"1994","journal-title":"Neurology"},{"key":"10.1053\/apmr.2001.25141_bib23","first-page":"68","year":"1993"},{"key":"10.1053\/apmr.2001.25141_bib24","first-page":"51","article-title":"Functional management of spasticity after head injury","volume":"5","author":"Mann","year":"1991","journal-title":"J Neurol Rehabil"},{"issue":"1","key":"10.1053\/apmr.2001.25141_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00001199-199702000-00012","article-title":"Pharmacology update: intrathecal baclofen for spastic hypertonia in brain injury","volume":"12","author":"Meythaler","year":"1996","journal-title":"J Head Trauma Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00006123-199605000-00015","article-title":"Continuous intrathecal baclofen for symptomatic generalized dystonia","volume":"38","author":"Albright","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1053\/apmr.2001.25141_bib27","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archneur.1996.00550120049016","article-title":"Use of intrathecal baclofen in the treatment of patients with dystonia","volume":"53","author":"Ford","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1053\/apmr.2001.25141_bib28","first-page":"193","article-title":"Clonidine effect on spasticity: a clinical trial","volume":"69","author":"Donovan","year":"1988","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1053\/apmr.2001.25141_bib29","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","article-title":"Traditional pharmacological treatments for spasticity. Part II: general and regional treatments","volume":"6","author":"Gracies","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1053\/apmr.2001.25141_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(86)90035-X","article-title":"Comparison of alpha-adrenoceptor involvement in the antinociceptive action of tizanidine and clonidine in the mouse","volume":"125","author":"Kameyama","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1053\/apmr.2001.25141_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1476-5381.1984.tb10776.x","article-title":"Selective antinociceptive effects of tizanidine (DS 103\u2013282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord","volume":"82","author":"Davies","year":"1984","journal-title":"Br J Pharmacol"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib32","first-page":"S29","article-title":"Pharmacokinetics and pharmacodynamics of tizanidine","volume":"44","author":"Roberts","year":"1994","journal-title":"Neurology"},{"key":"10.1053\/apmr.2001.25141_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1185\/03007998809111122","article-title":"Rohmer F, Warter JM. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia","volume":"10","author":"Bes","year":"1988","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/apmr.2001.25141_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1185\/03007998909110141","article-title":"A double-blind, long term study of tizanidine (\u2018Sirdalud\u2019) in spasticity due to cerebrovascular lesions","volume":"11","author":"Medici","year":"1989","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/apmr.2001.25141_bib35","first-page":"621","article-title":"Flexor reflex for assessment of common interneurone activity in spasticity","volume":"32","author":"Milanov","year":"1992","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"10.1053\/apmr.2001.25141_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0404.1994.tb01680.x","article-title":"Mechanisms of tizanidine action on spasticity","volume":"89","author":"Milanov","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/apmr.2001.25141_bib37","first-page":"22","article-title":"Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke] [Russian","volume":"98","author":"Gekht","year":"1998","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"11 Suppl 9","key":"10.1053\/apmr.2001.25141_bib38","first-page":"S53","article-title":"Comparative profile of tizanidine in the management of spasticity","volume":"44","author":"Lataste","year":"1994","journal-title":"Neurology"},{"key":"10.1053\/apmr.2001.25141_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00002826-199204000-00008","article-title":"Tizanidine in cranial dystonia","volume":"15","author":"Lang","year":"1992","journal-title":"Clin Neurpharmacol"},{"key":"10.1053\/apmr.2001.25141_bib40","first-page":"793","article-title":"The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent","volume":"30","author":"Sayers","year":"1980","journal-title":"Arzneimittelforshung"},{"key":"10.1053\/apmr.2001.25141_bib41","series-title":"Physician's desk reference","author":"Zanaflex","year":"1999"},{"key":"10.1053\/apmr.2001.25141_bib42","first-page":"129","article-title":"Pharmacologic modulation of recovery after stroke: clinical data","volume":"5","author":"Goldstein","year":"1991","journal-title":"J Neurol Rehabil"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999301739500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999301739500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:54:38Z","timestamp":1682139278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999301739500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0003999301739500"],"URL":"https:\/\/doi.org\/10.1053\/apmr.2001.25141","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}